New Issue: JPMorgan prices $1.16 million capped knock-out notes linked to Pfizer

By Angela McDaniels

Tacoma, Wash., Nov. 22 - JPMorgan Chase & Co. priced $1.16 million of 0% capped single observation knock-out notes due Dec. 5, 2012 linked to the common stock of Pfizer Inc., according to a 424B2 filing with the Securities and Exchange Commission.

If the final share price is at least 80% of the initial share price, the payout at maturity will be par plus the stock return, subject to a minimum return of 8.63% and a maximum return of 20%.

If the final share price is less than 80% of the initial share price, investors will be fully exposed to the decline from the initial share price.

J.P. Morgan Securities LLC is the agent.

Issuer:	JPMorgan Chase & Co.
Issue:	Capped single observation knock-out notes
Underlying stock:	Pfizer Inc. (NYSE: PFE)
Amount:	$1,161,000
Maturity:	Dec. 5, 2012
Coupon:	0%
Price:	Par
Payout at maturity:	If final price of Pfizer stock is less than 80% of initial share price, full exposure to decline from initial share price; otherwise, par plus stock return, subject to minimum return of 8.63% and maximum return of 20%
Initial share price:	$19.53
Pricing date:	Nov. 18
Settlement date:	Nov. 23
Agent:	J.P. Morgan Securities LLC
Fees:	1%
Cusip:	48125VCY4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.